BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 12666583)

  • 1. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global review of multidrug therapy (MDT) in leprosy.
    Noordeen SK; Lopez Bravo L; Daumerie D
    World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of leprosy as a public health problem: progress and prospects.
    Noordeen SK
    Bull World Health Organ; 1995; 73(1):1-6. PubMed ID: 7704919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
    Richardus JH; Habbema JD
    Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy in the WHO African region.
    Daumerie D
    World Health Stat Q; 1991; 44(1):16-22. PubMed ID: 2068820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leprosy control through multidrug therapy (MDT).
    Noordeen SK
    Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy situation in endemic states of India and prospects of elimination of the disease.
    Subramanian M; Showkath Ali MK; Thorat DM; Muthukumar M; Sathiskumar E; Ramadoss C; Ali Khan M
    Indian J Lepr; 2003; 75(4):335-45. PubMed ID: 15242272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
    Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in leprosy case detection worldwide since 1985.
    Meima A; Richardus JH; Habbema JD
    Lepr Rev; 2004 Mar; 75(1):19-33. PubMed ID: 15072123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy: too complex a disease for a simple elimination paradigm.
    Lockwood DN; Suneetha S
    Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
    WHO Regional Office for South-East Asia
    Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
    [No Abstract]   [Full Text] [Related]  

  • 19. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliminating leprosy as a public health problem--is the optimism justified?
    Noordeen SK; Roxas MG; Fine PE; Smith WC; Feenstra P; Gokhale SD; Joo LK; Huan-Ying L; Khalafalla G; Becx-Bleumink M; Srinivasan H; Rao CK; Lechat MF; Sansarricq H
    World Health Forum; 1996; 17(2):109-44. PubMed ID: 8936264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.